OBESITY

Faster Results with Rapid Execution

Leverage IQVIA’s global CRO expertise to accelerate obesity clinical trial timelines through proven execution, expert teams, and advanced patient recruitment strategies.

  • Experts in assistance with endpoints selection based on key global regulatory guidance and procedures
  • Use of exclusive datasets to inform in-development strategy change in a rapidly evolving landscape
  • Patient journey mapping using real world data to identify onset of obesity-related comorbidities to inform lifecycle management strategy
  • Private site network access boosts total enrollment numbers
  • Site activation efficiencies for clients to access a diverse patient population and reduce cycle time
  • Novel trial design
  • Targeted real-time optimization to recruit the right patients in real time
  • Patient Navigators and programs to enhance patient retention tailored to nutritional guidance
  • Centralized real-time data cleaning for swift trial closure
  • Our connected systems help inform your trials, including guidance on devices and endpoints through clinical data oversight
  • Site advisory and technology ecosystem integration creates pathways for effective use of data sources
  • eCOA catalog of connected devices for data oversight

Leverage our cross-therapeutic expertise to treat obesity related comorbidities

OBESITY

Keep patients at the center of development

The global burden of obesity is rising, with 1 billion people worldwide expected to have obesity by 2030.

IQVIA is redefining the obesity clinical trial experience with innovative strategies that accelerate patient recruitment, enhance site operations, and ensure robust, reliable data collection. By embedding COA-driven strategies, we help sponsors differentiate assets in a crowded market and demonstrate meaningful patient impact.

Obesity clinical trials are complex and need an integrated strategy

IQVIA's Experience
>100 trials

With ~54K patients enrolled in 50+ countries across ~2K sites in the past 5 years

IQVIA's Experience
100%

Of GLP-1 drugs included IQVIA’s services for clinical development and patient access and support

IQVIA Institute Obesity Insights and Intelligence

The IQVIA Institute offers stakeholder data, evidence and insights about important topics related to obesity, such as research methodologies, health economic implications and more.

Tackling Obesity: Knowledge Hub

Stay ahead of the curve by taking advantage of our industry insights on the global health challenges around obesity.

Related Solutions

Contact Us